Mobility Limitation

1
Pipeline Programs
2
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Cytokinetics
CytokineticsSOUTH SAN FRANCISCO, CA
1 program
1
reldesemtivPhase 1
Astellas
AstellasChina - Shenyang
1 program
Resistance TrainingN/A1 trial
Active Trials
NCT03083275Completed70Est. Feb 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AstellasResistance Training

Clinical Trials (1)

Total enrollment: 70 patients across 1 trials

NCT03083275AstellasResistance Training

Resistance Training in Older Adults With Limitations in Mobility

Start: Jan 2016Est. completion: Feb 201770 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space